Page 65 - MemoriaCIBER2019-ENG

CIBEREHD 65
Presentation by the Scientific Director
Jordi Bruix Tudó
In 2019, the constant approach of high-level scientific activity continued, with numerous publications in high-impact journals. In many cases, the results obtained have had a direct impact on patients’ health care. This translation evi- dences the consolidation of the CIBEREHD as a powerful research structure with significant benefit for the community. All of this was accomplished despite budgetary difficulties and the limitations to make new hires.
The annual report sets forth the most relevant results in the various CIBEREHD Programmes where we are able to wit- ness the progressive increase in collaborative studies with international impact in all the programmes both in Spain and abroad. Interestingly, international collaborations are frequently led by researchers from the CIBEREHD, bringing international recognition as a result.
Research has been relevant in basic aspects but, as has been highlighted, the most significant aspect has been in the translation to patients affected by liver and digestive diseases. Various clinical practice guidelines based on scientific evidence have been published, as well as consensus documents defining the criteria and methods that must be fol- lowed in both basic and clinical research.
Scientific Management and the Management Committee as a whole continue to implement the four-year action plan although the description of the activity has been redesigned based on collaborative projects. Generational renewal and genderbalancing has been ongoing on all levels. Moreover, we continue to identify young researchers with scien- tific career ambitions in order to guarantee maintenance of research culture in Biomedicine.